Exelixis, Genomica Merger Passes End of Initial Offering Period | GenomeWeb

SAN FRANCISCO, Jan. 2 - The proposed Genomica-Exelixis merger reached the close of its initial offering period for the exchange of its stock on Dec. 28 at Eastern Standard Time, Exelixis said on Wednesday.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.